Skip to main content

Table 2 Distribution of measurable and non-measurable lesions on baseline PET-CT

From: Long-term outcomes and recurrence pattern of 18F-FDG PET-CT complete metabolic response in the first-line treatment of metastatic colorectal cancer: a lesion-based and patient-based analysis

  Metastatic sites Measurable lesions Non-measurable lesions
Total No 59 44 38
Liver 17 27 5
Lung 6 1 5
Lymph Nodes 20 7 18
Peritoneal 11 7 7
Others 5 2 3